RPS6KB1 and cardiac hypertrophy: These authors suggested an inhibition of AMP-activated protein kinase (AMPK), which behaves as a negative regulator of cardiac hypertrophy, activating the mTOR/p70S6K pathway, which increases protein synthesis associated with cardiac hypertrophy.